Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Nurs Res ; 31(6): 1100-1106, 2022 07.
Article in English | MEDLINE | ID: mdl-35450451

ABSTRACT

BACKGROUND: To investigate the efficacy of individualized symptom management based on patients' self-reports during interventional therapy (IT) for liver cancer. METHODS: Patients with liver cancer who recieved IT from April to August 2019 were assigned to either the intervention (n=70) or control group (n=70). The control group received routine nursing care and the intervention group received a nursing management program. The severity of specific symptoms, as measured by the Karnofsky Performance Scale (KPS), and satisfaction with nursing care, were analyzed. RESULTS: Compared to the control group, patients given individualized management experienced significantly less severe pain, nausea, anxiety, and fatigue (p < .05). The scores for KPS and satisfaction with care were both significantly improved in the intervention group than in the control group (p < .05). CONCLUSION: This high-quality nursing management program predicated on patients' self-reports is worthy of clinical application and popular adoption.


Subject(s)
Fatigue , Liver Neoplasms , Anxiety , Humans , Liver Neoplasms/therapy , Nausea , Patient Reported Outcome Measures
2.
Int J Clin Exp Pathol ; 13(7): 1693-1697, 2020.
Article in English | MEDLINE | ID: mdl-32782691

ABSTRACT

Breast carcinoma retroperitoneal metastasis is rare. The clinical symptoms of this disease are always non-specific. Laboratory tests are not always helpful for diagnosis and evaluation. We reported a case of a 52 year old Chinese patient who was diagnosed with retroperitoneal metastasis from breast invasive ductal carcinoma as the first site of distant metastasis synchronous with brain and mediastinal lymph nodes metastasis 4 years after modified radical mastectomy. Second-line chemotherapy of docetaxel and capecitabine was recommended. The response evaluation every two to three months was good. Unfortunately, the metastasis in the brain advanced. The patient was transferred to a radiotherapy department to receive radiotherapy and died 10 months later. We also review the related literature.

SELECTION OF CITATIONS
SEARCH DETAIL
...